1 / 12

United States Generic Drugs Market Forecast

For more Info: <br><br>https://www.renub.com/united-states-generic-drugs-market-nd.php<br><br>As per Renub Research analysis United States Generic Drugs Market is anticipated to be more than USD 210 Billion by the year 2024. It has approximately 80% share of total dispensing prescriptions. Now most of the physicians and hospitals like prescribe generic drugs as compared to branded drugs.<br><br>What is a Generic Drug?<br><br>It is a Pharmaceutical drug that has the same chemical composition as patented drug. It has the same Active Pharmaceutical Ingredient (API) as original, but may have different manufacturing process, excipients, color, taste and packaging. It is only allowed when the patent(s) of on original drug is expired.<br> <br>Request a free sample copy of the report: <br><br>https://www.renub.com/contactus.php<br> <br>Generic Drugs Market in United States<br><br>In 2007, the Food and Drug Administration (FDA) launched the Generic Initiative for Value and Efficiency (GIVE) to increase the number and a variety of generic products by modernizing and streamlining approval process for generic drugs in US. For making a generic drug, pharmaceutical companies are required to file an Abbreviated New Drug Application with FDA.<br> <br>Why Generic Drugs are more affordable than Branded Drugs?<br><br>A branded drug has to go through many phases before coming into the market; initial phase is drug discovery, target identification and validation then Primary Screening, Secondary Screening, Lead Optimization, Pre-Clinical Animal Studies and various other tests. As new drug development is a complex process and involves various R & D of chemicals, but clinical trials and regulatory processes are also required to be approved for human use of drugs. <br>

renubresearch
Download Presentation

United States Generic Drugs Market Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Category: Drugs & Pharmaceuticals Market Report

  2. United States Generic Drugs Market Analyst View: • United States Generic Drugs Market to be USD 210 Billion by 2024. GetFree Customization in this Report • Press Release Title: • United States Generic Drugs Market to be USD 210 Billion by 2024. • For more Info: • https://www.renub.com/united-states-generic-drugs-market-nd.php

  3. United States Generic Drugs Market is projected to exceed USD 210 Billion by 2024. • Research Report Title: • United States Generic Drugs Market, By Therapeutic Application [Central Nervous System (CNS), Cardiovascular, Dermatology, Genitourinary (GU)/Harmonal Drugs, Respiratory, Anti-infective, Oncology & Others], Companies (Teva, Mylan N.V., Sandoz, Endo Pharmaceuticals, Lupin Limited, Dr Reddy’s, Sun Pharma, & Others) • Access Full Research:  • https://www.renub.com/united-states-off-label-drugs-market-and-forecast-51-p.php • As per Renub Research analysis United States Generic Drugs Market is anticipated to be more than USD 210 Billion by the year 2024. It has approximately 80% share of total dispensing prescriptions. Now most of the physicians and hospitals like prescribe generic drugs as compared to branded drugs.

  4. United States Generic Drugs Market is projected to exceed USD 210 Billion by 2024. What is a Generic Drug? It is a Pharmaceutical drug that has the same chemical composition as patented drug. It has the same Active Pharmaceutical Ingredient (API) as original, but may have different manufacturing process, excipients, color, taste and packaging. It is only allowed when the patent(s) of on original drug is expired. Request a free sample copy of the report: https://www.renub.com/contactus.php Generic Drugs Market in United States In 2007, the Food and Drug Administration (FDA) launched the Generic Initiative for Value and Efficiency (GIVE) to increase the number and a variety of generic products by modernizing & streamlining approval process for generic drugs in US. For making a generic drug, pharmaceutical companies are required to file an Abbreviated New Drug Application with FDA.

  5. United States Generic Drugs Market is projected to exceed USD 210 Billion by 2024.

  6. United States Generic Drugs Market is projected to exceed USD 210 Billion by 2024. Why Generic Drugs are more affordable than Branded Drugs? A branded drug has to go through many phases before coming into the market; initial phase is drug discovery, target identification and validation then Primary Screening, Secondary Screening, Lead Optimization, Pre-Clinical Animal Studies and various other tests. As new drug development is a complex process and involves various R & D of chemicals, but clinical trials and regulatory processes are also required to be approved for human use of drugs. How Drugs Development Process Works? According to some studies only 5 out of 5000 preclinical drugs are tested on the human for medical use out of those 5 drugs only 1 is approved by FDA. There are various stages involved in drug development.  Drug Discovery and Target Validation:In this stage drug development company chooses a molecule, such as a protein or gene and test it with a drug. After testing multiple drugs only a few are selected for next stage.

  7. United States Generic Drugs Market is projected to exceed USD 210 Billion by 2024. Preclinical Testing:It is divided into subcomponents: in vitro and in vivo testing. In vitro testing examines drug molecules interactions in test tubes in the lab setting. In vivo testing involves test is being done on animal models and other living cell cultures. These tests may take several years before going to next stage. Investigational New Drug Application Filing:At this stage an application is submitted to FDA before beginning human clinical trials. At this point FDA will scrutinize the outcomes of preclinical testing, side effects and other safety measures for an experimental drug. When IND got approved by FDA then it can move onto human trials. After IND approval a patented drugs' 20 year exclusivity period begins. Phase 1 Clinical Studies:At this stage testing involves a small group of healthy people from a dozen to a few in numbers and safety is taken as a primary concern. Now all the side effect of drug, how a drug is absorbed & elimination from the body is tested. Phase 2 Clinical Studies: After getting positive outcomes from Phase1, Phase 2 begins in this phase the number of patients grows from a few dozen to 100 or more patients who are suffering from disease. Safety is also a big concern at this point and short term side effects are also monitored closely. 

  8. United States Generic Drugs Market is projected to exceed USD 210 Billion by 2024. Client can Purchase this Report in Sections from below link: https://www.renub.com/united-states-off-label-drugs-market-and-forecast-51-p.php Phase 3 Clinical Studies:At this stage the number of patients for drug testing grow from a few hundred to thousands. It is the longest and costliest of all components of development process. New Drug Application Filing:At this point application is filed to FDA, with all the research and safety data of initial stages having tens of thousands to 100,000 or more pages. After getting affirmation from FDA, Prescription Drug User Fee Act (PDUFA) date is set 10 months.PDUFA Date and Decision:FDA will wait for PDUFA date for its decision. FDA has 3 choices: it can approve a drug, it can deny a drug or it can request additional information by sending a Complete Response Later (CRL). If a drug is approved by FDA, now it becomes immediately available for commercial production.  Phase 4 Clinical Studies: After 8 steps an approved drug can used for medical purpose, but it doesn't mean it is not under scrutiny of FDA, FDA can request long-term safety measures, side effect and adverse effect of drug.

  9. Table of Contents for United States Generic Drugs Market Key Topics Covered 1. Executive Summary 2. United States Pharmaceutical Market 2.1 Branded Pharmaceutical Market 2.2 Generics Pharmaceutical Market 3. United States Generic Drugs Saving 4. Market Share – United States Pharmaceutical 4.1 Branded vs. Generics Drugs 4.2 Branded Generic vs. Unbranded Generic Drug 4.3 Volume Penetration – Generic vs. Branded Drugs 4.4 Therapeutic Application 5. United States Generic Drugs Market (2010 – 2024) 5.1 Branded Generic Drugs Market 5.2 Unbranded Generic Drugs Market

  10. Table of Contents for United States Generic Drugs Market 6. Therapeutic Application – United States Generic Drugs Market (2010 – 2024) 6.1 Central Nervous System (CNS) 6.2 Cardiovascular 6.3 Dermatology 6.4 Genitourinary / Hormonal Drugs 6.5 Respiratory 6.6 Anti-infective 6.7 Oncology 6.8 Others 7. Teva Pharmaceutical Industries Ltd - Company Analysis 7.1 Product Launch 7.2 Financial Insight 8. Mylan N.V. - Company Analysis 8.1 Product Launch 8.2 Financial Insight 9. Sandoz Inc. - Company Analysis 9.1 Product Launch 9.2 Financial Insight 10. Endo Pharmaceuticals - Company Analysis 10.1 Product Launch 10.2 Financial Insight

  11. Table of Contents for United States Generic Drugs Market 11. Lupin Limited - Company Analysis 11.1 Product Launch 11.2 Financial Insight 12. Dr Reddy's - Company Analysis 12.1 Business Portfolio 12.2 Financial Insight 13. Sun Pharmaceutical Industries Ltd. - Company Analysis 13.1 Product Launch 13.2 Financial Insight 14. Others 14.1 Financial Insight 15. Growth Driver 15.1 Rising Geriatric Population of United States 15.2 Generic Drugs Cost less than Brand Name Drugs 15.3 Rising Incidence of non-communicable Diseases 16. Challenges 16.1 Lack of Regulation & Information 16.2 Long Halt for Expiration of Patent Drug

  12. GetFree Customization in this Report • Drugs & Pharmaceuticals Market Reports: • https://www.renub.com/drugs-and-pharmaceuticals-13-c.php

More Related